Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease
Casper Steenholdt, Klaus Bendtzen, Jørn Brynskov, Ole Ø Thomsen, Lars K Munck, Lisbet A Christensen, Gitte Pedersen, Jens Kjeldsen, Mark A Ainsworth
Dive into the research topics of 'Changes in serum trough levels of infliximab during treatment intensification but not in anti-infliximab antibody detection are associated with clinical outcomes after therapeutic failure in Crohn's disease'. Together they form a unique fingerprint.